Active Ingredient History

NOW
  • Now
Ranimustine is a nitrosourea alkylating agent approved in Japan for the treatment of chronic myelogenous leukemia and polycythemia vera.   Wikipedia

  • SMILES: CO[C@H]1O[C@H](CNC(=O)N(CCCl)N=O)[C@@H](O)[C@H](O)[C@H]1O
  • InChIKey: AHHFEZNOXOZZQA-ZEBDFXRSSA-N
  • Mol. Mass: 327.72
  • ALogP: -1.63
  • ChEMBL Molecule:
More Chemistry
  • Mechanism of Action:
  • Multi-specific: Missing data
  • Black Box: No
  • Availability: Missing data
  • Delivery Methods: Missing data
  • Pro Drug: No
alpha-d-glucopyranoside, methyl 6-((((2-chloroethyl)nitrosoamino)carbonyl)amino)-6-deoxy- | cymerin | cymerine | mcnu | methyl 6-((((2-chloroethyl)nitrosoamino)carbonyl) amino)-6-deoxy-alpha-d-glucopyranoside | methyl 6-(3-(2-chloroethyl)-3-nitrosoiureido)-6-deoxy-alpha-d-glucopyranoside | methyl 6-(3-(2-chloroethyl)-3-nitrosoureido)-6-deoxy-alpha-d-glucopyranoside | ranimustine | ranimustine, (beta)-(d)-isomer

Feedback

Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue